Changeflow GovPing Healthcare USPTO Patent US12582326B2: Leak detection metho...
Routine Guidance Added Final

USPTO Patent US12582326B2: Leak detection method for hollow organs

Favicon for changeflow.com ChangeBridge: Patent Grants - Medical Devices (A61M)
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has granted patent US12582326B2 to QAELON MEDICAL for a method and system for automatically detecting clinically relevant leaks following medical procedures. The patent describes a technique involving injecting a test gas into a hollow organ and measuring its concentration in the body cavity to assess leak severity.

What changed

The United States Patent and Trademark Office (USPTO) has issued patent US12582326B2, titled 'Leak detection method for hollow organs,' to QAELON MEDICAL. This patent details a novel method for automatically detecting leaks or inadequate closures in hollow organs after medical procedures. The technique involves injecting a test gas into the organ and measuring its concentration within the body cavity to evaluate the presence and severity of any leak, with controlled pressure differences.

While patent grants are not direct regulations, this innovation may influence future medical device development and surgical practices. Medical device manufacturers and healthcare providers involved in procedures where organ integrity is critical should be aware of this patented technology. Compliance officers in the medical device sector may need to consider this patent for intellectual property due diligence and product development strategies.

Source document (simplified)

← USPTO Patent Grants

Method and system for automatically detecting a clinically relevant leak

Grant US12582326B2 Kind: B2 Mar 24, 2026

Assignee

QAELON MEDICAL

Inventors

Lee Swanström, Michele Diana, Bruno Mutet, Eran Shlomowitz

Abstract

A method for automatically detecting a clinically relevant leak and/or inadequate closure following a medical procedure, in a hollow organ residing in the interior volume of a body cavity. The test method includes the steps of: injecting, via an adapted injection element, a specific test gas or a gas mixture containing at least one test gas, into the organ, analyzing the gas mixture and measuring the test gas concentration in the interior volume of the body cavity via an adapted detection element and at least during a measurement window, evaluating the likelihood of the presence of a leak and its degree of severity, by comparing stored data and real-time data with each other. The pressure difference between the interior of the hollow organ(s) and the interior volume of the body cavity is controlled or mastered at least at a given moment during at least one measurement window.

CPC Classifications

A61B 5/036 A61B 5/4255 A61B 17/11 A61B 2505/05 A61B 5/4842 A61M 2202/0283 A61M 2205/15 A61M 2205/3344 A61M 13/003 A61M 2205/502 A61M 2205/70

Filing Date

2020-12-17

Application No.

17785304

Claims

19

View original document →

Named provisions

Method and system for automatically detecting a clinically relevant leak

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Guidance
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582326B2

Who this affects

Applies to
Drug manufacturers Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Innovation Surgical Procedure Monitoring
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Product Development
Topics
Healthcare Technology Surgical Procedures

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.